One of my laggards had a big day last night, after their meeting with their FDA. I suppose I could exit with a small gain after averaging down, but after the trials and tribulations of the former incompetent CEO, I'm tempted to wait it out until FDA approval. Surfaxin will save many lives with Respiratory Distress Syndrome, so I will hang in there.
http://philadelphia.bizjournals.com/philadelphia/stories/2009/09/28/daily17.html?ana=yfcpc
There was a chance Discover Laboratories (symbol "DSCO") would be forced to shut its doors, but there was just too much technology for it to collapse. A partnership, and accompanying cash, should enable DSCO to reach the finish line.
Disclosure: I am long shares of DSCO.
Wednesday, September 30, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment